ARAB PHARMACEUTICALSARAB PHARMACEUTICALSARAB PHARMACEUTICALS

ARAB PHARMACEUTICALS

No trades
See on Supercharts
Market capitalization
‪619.26 M‬EGP
13.779EGP
‪71.13 M‬EGP
‪633.73 M‬EGP
Beta (1Y)
0.21

About ARAB PHARMACEUTICALS


Headquarters
Cairo
Founded
1964
ISIN
EGS38321C013
FIGI
BBG000BYC393
Arab Pharmaceuticals engages in the manufacture, packaging, distribution and trade of drugs, pharmaceuticals, and chemicals. Its products include ampoules, tablets, syrups, solutions, capsules, aerosol sprays, metered dose inhalers, granulated powder for suspension, creams, ointments, and suppositories. The company is also involved in the purchase and sale of compounds, raw materials, and related products. Arab Pharmaceuticals was founded on November 7, 1964 and is headquartered in Cairo, Egypt.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ADCI is 104.560 EGP — it has increased by 1.02% in the past 24 hours. Watch ARAB PHARMACEUTICALS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange ARAB PHARMACEUTICALS stocks are traded under the ticker ADCI.
ADCI stock has risen by 1.31% compared to the previous week, the month change is a 2.85% rise, over the last year ARAB PHARMACEUTICALS has showed a 55.94% increase.
ADCI reached its all-time high on Oct 27, 2024 with the price of 119.000 EGP, and its all-time low was 5.450 EGP and was reached on Feb 14, 2016. View more price dynamics on ADCI chart.
See other stocks reaching their highest and lowest prices.
ADCI stock is 3.67% volatile and has beta coefficient of 0.21. Track ARAB PHARMACEUTICALS stock price on the chart and check out the list of the most volatile stocks — is ARAB PHARMACEUTICALS there?
Yes, you can track ARAB PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
ADCI net income for the last quarter is ‪14.52 M‬ EGP, while the quarter before that showed ‪32.81 M‬ EGP of net income which accounts for −55.74% change. Track more ARAB PHARMACEUTICALS financial stats to get the full picture.
Yes, ADCI dividends are paid annually. The last dividend per share was 8.35 EGP. As of today, Dividend Yield (TTM)% is 8.09%. Tracking ARAB PHARMACEUTICALS dividends might help you take more informed decisions.
ARAB PHARMACEUTICALS dividend yield was 6.73% in 2023, and payout ratio reached 37.96%. The year before the numbers were 10.47% and 37.75% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARAB PHARMACEUTICALS EBITDA is ‪113.80 M‬ EGP, and current EBITDA margin is 18.48%. See more stats in ARAB PHARMACEUTICALS financial statements.
Like other stocks, ADCI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARAB PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARAB PHARMACEUTICALS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARAB PHARMACEUTICALS stock shows the buy signal. See more of ARAB PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.